Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Benlysta
Benlysta
GSK receives orphan drug designation for Benlysta to treat systemic sclerosis
GSK receives orphan drug designation for Benlysta to treat systemic sclerosis
Pharmaceutical Business Review
GSK
FDA
orphan drugs
Benlysta
systemic sclerosis
Flag link:
GSK survey finds COVID, lack of early HCP conversations hitting lupus patients' care
GSK survey finds COVID, lack of early HCP conversations hitting lupus patients' care
Fierce Pharma
GSK
lupus
Benlysta
patients
COVID-19
pharma marketing
Flag link:
AstraZeneca nabs FDA nod to challenge GSK's Benlysta with first-in-class lupus drug Saphnelo
AstraZeneca nabs FDA nod to challenge GSK's Benlysta with first-in-class lupus drug Saphnelo
Fierce Pharma
AstraZeneca
GSK
FDA
lupus
Saphnelo
systemic lupus erythematosus
Benlysta
Flag link:
GlaxoSmithKline debuts DTC campaign for lupus med Benlysta as it looks to cement category lead
GlaxoSmithKline debuts DTC campaign for lupus med Benlysta as it looks to cement category lead
Fierce Pharma
GSK
lupus
Benlysta
DTC advertising
Flag link:
As GSK, Aurinia heat up the lupus nephritis category, analyst gauges doctors' first impressions
As GSK, Aurinia heat up the lupus nephritis category, analyst gauges doctors' first impressions
Fierce Pharma
GSK
Aurinia
lupus nephritis
Benlysta
Lupkynis
FDA
Flag link:
After losing race for first to market in lupus nephritis, Aurinia taps Otsuka for voclosporin licensing pact abroad
After losing race for first to market in lupus nephritis, Aurinia taps Otsuka for voclosporin licensing pact abroad
Endpoints
Aurinia Pharmaceuticals
lupus nephritis
GSK
Otsuka
Benlysta
Flag link:
AstraZeneca lupus drug shows potential, but it may not be enough for FDA
AstraZeneca lupus drug shows potential, but it may not be enough for FDA
Biopharma Dive
AstraZeneca
lupus
anifrolumab
GSK
Benlysta
Flag link:
GlaxoSmithKline's Benlysta eyes lupus sales boost after kidney trial win
GlaxoSmithKline's Benlysta eyes lupus sales boost after kidney trial win
Fierce Pharma
GSK
Benlysta
lupus
Flag link:
GSK gets FDA nod for Benlysta to treat pediatric patients with lupus
GSK gets FDA nod for Benlysta to treat pediatric patients with lupus
Pharmaceutical Business Review
GSK
FDA
Benlysta
SLE
systemic lupus erythematosus
pediatrics
Flag link:
GSK trials Benlysta/rituximab combo for lupus
GSK trials Benlysta/rituximab combo for lupus
Pharma Times
GSK
clinical trials
Benlysta
rituximab
lupus
Flag link:
GSK gets go-ahead for new Benlysta formulation
GSK gets go-ahead for new Benlysta formulation
BioPharma Dive
GSK
Benlysta
systemic lupus erythematosus
SLE
Flag link:
Samsung Bioepis launches a Remicade knockoff at a 35% discount; FDA OK’s a self-administered version of Benlysta
Samsung Bioepis launches a Remicade knockoff at a 35% discount; FDA OK’s a self-administered version of Benlysta
Endpoints
Samsung Bioepis
Remicade
FDA
biosimilars
JNJ
GSK
Benlysta
lupus
Flag link:
5 Biotech Stocks With Major Catalysts in July
5 Biotech Stocks With Major Catalysts in July
Motley Fool
biotech
AcelRx
Zalviso
Alnylam
Patisiran
Dynavax
HEPLISAV-B
GSK
Benlysta
Puma Biotechnology
neratinib
Flag link:
Benlysta maker GSK drafts soccer star Boxx to get lupus patients talking
Benlysta maker GSK drafts soccer star Boxx to get lupus patients talking
Fierce Pharma
Benlysta
GSK
lupus
patients
Flag link:
GSK's lupus drug finally wins NICE backing, but only after discounts
GSK's lupus drug finally wins NICE backing, but only after discounts
BioPharma Dive
GSK
lupus
NICE
UK
Benlysta
Flag link:
AstraZeneca, GlaxoSmithKline stake rival claims on new lupus therapies
AstraZeneca, GlaxoSmithKline stake rival claims on new lupus therapies
Fierce Biotech
AstraZeneca
GSK
lupus
Benlysta
MEDI-546
Flag link:
AstraZeneca lupus drug produces positive results in trial
AstraZeneca lupus drug produces positive results in trial
Yahoo/Reuters
AstraZeneca
lupus
Benlysta
sifalimumab
Flag link:
GlaxoSmithKline Launches Phase 3 Trial for Benlysta
GlaxoSmithKline Launches Phase 3 Trial for Benlysta
Motley Fool
GSK
Benlysta
ANCA-positive vasculitis
Flag link:
10 top drug launch disasters
10 top drug launch disasters
Fierce Pharma
drug launches
Rare Disease Therapeutics
Anascorp
AstraZeneca
Brilinta
Somaxon
Silenor
Sanofi
Multaq
Savient
Krystexxa
XenoPort
Horizant
Human Genome Sciences
Benlysta
Zaltrap
Dendreon
Provenge
KV Pharmaceutical
Makena
Flag link:
Biogen Sells Benlysta Rights
Biogen Sells Benlysta Rights
Yahoo/Zacks
Biogen
Benlysta
GSK
Flag link:
Pages
1
2
3
4
5
next ›
last »